Search results for "RECEPTOR"

showing 10 items of 6990 documents

Effects of ovariectomy and steroid replacement on GABAA receptor binding in female rat brain.

1991

Abstract The specific binding of tritiated muscimol to γ-aminobutyric acid (GABA) receptor sites was studied in distinct brain areas of female rats during different endocrine states. In diestrous rats with intact ovaries the highest receptor densities were found in the cortex (10.24 pmol/mg protein) and the lowest concentrations in the mediobasal hypothalamus (3.29 pmol/mg protein). Four weeks after removal of the ovaries, the number of binding sites was enhanced up to 2.4-fold in all brain areas investigated: the preoptic brain area, mediobasal hypothalamus, corticomedial amygdala, and cerebral cortex. The affinity of the binding sites remained unchanged. Substitution of estradiol and prog…

medicine.medical_specialtyEndocrinology Diabetes and MetabolismOvariectomyClinical BiochemistryBiologyIn Vitro TechniquesTritiumBiochemistrySynaptic Transmissionchemistry.chemical_compoundEndocrinologyInternal medicineCortex (anatomy)medicineAnimalsReceptorMolecular BiologyProgesteroneEstradiolGABAA receptorMuscimolBrainRats Inbred StrainsCell BiologyLuteinizing HormoneReceptors GABA-ARatsPreoptic areamedicine.anatomical_structureEndocrinologynervous systemMuscimolchemistryCerebral cortexMolecular MedicineGABAergicFemaleHormoneThe Journal of steroid biochemistry and molecular biology
researchProduct

Genetic and environmental aspect of polycystic ovary syndrome.

2004

Polycystic ovary syndrome (PCOS) is a heterogeneous syndrome determined in most patients by the association of two main factors: hyperandrogenism and insulin resistance. These characters are probably independent of each other and seem to be inherited by several different mechanisms. In some patients homozygous gene alteration has been found but in most patients PCOS seems to be determined by the association of gene polymorphisms that are common in the general population but alone are unable to determine phenotypic consequences. Alteration of genes that regulate the initial steps of ovarian steroidogenesis is probably the main causal factor of hyperandrogenism. Insulin resistance may be the …

medicine.medical_specialtyEndocrinology Diabetes and MetabolismPopulationBiologyEatingEndocrinologyInsulin resistanceInternal medicineInsulin receptor substratemedicineHumansGenetic Predisposition to DiseaseObesityeducationGeneeducation.field_of_studyHyperandrogenismmedicine.diseaseObesityPhenotypePolycystic ovaryEndocrinologyFemaleInsulin ResistanceEnergy MetabolismHyperandrogenismPolycystic Ovary SyndromeJournal of endocrinological investigation
researchProduct

Emerging therapies for raising high-density lipoprotein cholesterol (HDL-C) and augmenting HDL particle functionality.

2014

High-density lipoprotein (HDL) particles are highly complex polymolecular aggregates capable of performing a remarkable range of atheroprotective functions. Considerable research is being performed throughout the world to develop novel pharmacologic approaches to: (1) promote apoprotein A-I and HDL particle biosynthesis; (2) augment capacity for reverse cholesterol transport so as to reduce risk for the development and progression of atherosclerotic disease; and (3) modulate the functionality of HDL particles in order to increase their capacity to antagonize oxidation, inflammation, thrombosis, endothelial dysfunction, insulin resistance, and other processes that participate in arterial wal…

medicine.medical_specialtyEndocrinology Diabetes and MetabolismRVX 208BiologyBioinformaticschemistry.chemical_compoundEndocrinologyInsulin resistanceHigh-density lipoproteinInternal medicinemedicineHumansEndothelial dysfunctionLiver X receptorDyslipidemiasTherapies InvestigationalReverse cholesterol transportCholesterol HDLGenetic Therapymedicine.diseaseUp-RegulationEndocrinologychemistryCardiovascular Diseaseslipids (amino acids peptides and proteins)Farnesoid X receptorLipoproteinBest practiceresearch. Clinical endocrinologymetabolism
researchProduct

Long-term effectiveness of agalsidase alfa enzyme replacement in Fabry disease: A Fabry Outcome Survey analysis

2015

Outcomes from 5 years of treatment with agalsidase alfa enzyme replacement therapy (ERT) for Fabry disease in patients enrolled in the Fabry Outcome Survey (FOS) were compared with published findings for untreated patients with Fabry disease. Data were extracted from FOS, a Shire-sponsored database, for comparison with data from three published studies. Outcomes evaluated were the annualized rate of change in estimated glomerular filtration rate (eGFR) and left ventricular mass indexed to height (LVMI) as well as time to and ages at a composite morbidity endpoint and at death. FOS data were extracted for 740 treated patients who were followed for a median of ~ 5 years. Compared with no trea…

medicine.medical_specialtyEndocrinology Diabetes and MetabolismUrologyCardiomyopathyRenal functionSE Standard errorLeft ventricular hypertrophyBiochemistryLVH Left ventricular hypertrophyLong-term effectivenessEndocrinologyGeneticsMedicineMDRD Modification of Diet in Renal Diseaselcsh:QH301-705.5Molecular BiologyAgalsidase alfaeGFR Estimated glomerular filtration rateFabry diseaselcsh:R5-920CI Confidence intervalbusiness.industryEnzyme replacement therapymedicine.diseaseEgfr Estimated glomerular filtration rateFabry diseaseSurgeryARB Angiotensin receptor blockerSEM Standard error of the meanStandard errorlcsh:Biology (General)SI:TherapyEnzyme replacement therapyCohortFOS Fabry Outcome SurveyLVMI Left ventricular mass indexed to heightlcsh:Medicine (General)businessACEI Angiotensin-converting enzyme inhibitorAgalsidase alfaERT Enzyme replacement therapyMolecular Genetics and Metabolism Reports
researchProduct

3H-cyproterone acetate: binding characteristics to human uterine progestagen receptors

1985

The availability of tritium labeled cyproterone acetate (CPA) facilitated the systematic investigation of the binding characteristics of this compound for human uterine progesterone receptors (PgR). The binding parameters of 3H-CPA are compared to those of 3H-R5020 and 3H-progesterone. The rate constants of association (k1M-1sec-1) to PgR were 7.8 X 10(3) for 3H-R5020, 4.5 X 10(4) for 3H-progesterone and 4.0 X 10(4) for 3H-CPA. The rate constants of dissociation (k-1, sec-1) were 3.6 X 10(-5) for 3H-R5020, 21.3 X 10(-5) for 3H-progesterone and 17.8 X 10(-5) for 3H-CPA. The Kd-values (M), as obtained by titration analysis and subsequent Scatchard plot analysis were 1.2 X 10(-9) for 3H-R5020,…

medicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentStatistics as TopicTritiumBinding CompetitivePromegestoneSteroidchemistry.chemical_compoundEndocrinologyInternal medicineCentrifugation Density GradientmedicineHumansPotencyheterocyclic compoundsCyproteroneBinding siteCyproterone AcetateReceptorProgesteroneUterusCyproterone acetateKineticsEndocrinologychemistryDihydrotestosteronecardiovascular systemCyproteroneFemaleTritiumReceptors Progesteronehormones hormone substitutes and hormone antagonistsmedicine.drugJournal of Endocrinological Investigation
researchProduct

Can Ketogenic Diet Improve Alzheimer's Disease? Association With Anxiety, Depression, and Glutamate System

2021

Background: Alzheimer's disease is the most common neurodegenerative disorder in our society, mainly characterized by loss of cognitive function. However, other symptoms such as anxiety and depression have been described in patients. The process is mediated by alterations in the synaptic and extrasynaptic activity of the neurotransmitter glutamate, which are linked to a hypometabolism of glucose as the main source of brain energy. In that respect, Ketogenic diet (KD) has been proposed as a non-pharmacological treatment serving as an alternative energy source to the neurons increasing the fat percentage and reducing the carbohydrates percentage, showing promising results to improve the cogni…

medicine.medical_specialtyEndocrinology Diabetes and Metabolismmedicine.medical_treatmentketogenic dietsglutamateDiseaseNeurotransmissionchemistry.chemical_compoundInternal medicinemedicineTX341-641NeurotransmitterDepression (differential diagnoses)NutritionNutrition and Dieteticsbusiness.industryNutrition. Foods and food supplyGlutamate receptorCognitionAlzheimer's diseaseanxietyEndocrinologychemistryPerspectivedepressionAnxietymedicine.symptombusinessFood ScienceKetogenic dietFrontiers in Nutrition
researchProduct

Absence of CCR3 receptor accelerates atherosclerosis in apoE-/- mice

2018

medicine.medical_specialtyEndocrinologyApoe micebusiness.industryApplied MathematicsGeneral MathematicsInternal medicineCCR3medicinebusinessReceptorProceedings for Annual Meeting of The Japanese Pharmacological Society
researchProduct

Dissecting the molecular antifibrotic effect of the TGF-Beta(I) receptor kinase inhibitor galunisertib in precision-cut liver slices

2016

medicine.medical_specialtyEndocrinologyHepatologyKinaseChemistryInternal medicineTGF beta signaling pathwayCancer researchmedicineGalunisertibReceptorJournal of Hepatology
researchProduct

P045 Local inflammation modulates vitamin D receptor protein levels in fibroblasts

2019

medicine.medical_specialtyEndocrinologybusiness.industryInternal medicineGastroenterologymedicineInflammationGeneral Medicinemedicine.symptombusinessCalcitriol receptorJournal of Crohn's and Colitis
researchProduct

Enhanced levels of the light/lymphotoxin-beta receptor inflammatory axis in metabolic syndrome patients

2014

medicine.medical_specialtyEndocrinologybusiness.industryInternal medicinemedicineMetabolic syndromeCardiology and Cardiovascular MedicineLymphotoxin beta receptormedicine.diseasebusinessAtherosclerosis
researchProduct